Sorafenib cardiotoxicity increases mortality after myocardial infarction. (Record no. 23723913)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02079 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516205345.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201407s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1524-4571 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1161/CIRCRESAHA.114.303200 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Duran, Jason M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20140714 |
| 245 00 - TITLE STATEMENT | |
| Title | Sorafenib cardiotoxicity increases mortality after myocardial infarction. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Circulation research |
| Date of publication, distribution, etc. | May 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1700-1712 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Apoptosis |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cats |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Proliferation |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cells, Cultured |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Models, Animal |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heart |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | In Vitro Techniques |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Metoprolol |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Inbred C57BL |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Myocardial Infarction |
| General subdivision | mortality |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Myocytes, Cardiac |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Niacinamide |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenylurea Compounds |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proto-Oncogene Proteins c-kit |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sorafenib |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Makarewich, Catherine A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Trappanese, Danielle |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gross, Polina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Husain, Sharmeen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dunn, Jonathan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lal, Hind |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sharp, Thomas E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Starosta, Timothy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vagnozzi, Ronald J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berretta, Remus M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barbe, Mary |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yu, Daohai |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gao, Erhe |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kubo, Hajime |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Force, Thomas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Houser, Steven R |
| 773 0# - HOST ITEM ENTRY | |
| Title | Circulation research |
| Related parts | vol. 114 |
| -- | no. 11 |
| -- | p. 1700-1712 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1161/CIRCRESAHA.114.303200">https://doi.org/10.1161/CIRCRESAHA.114.303200</a> |
| Public note | Available from publisher's website |
No items available.